Loading

Merlin Biotech, Inc.

June 04, 2024
Start-Up Stadium Session
Oncology
5B
Merlin has a pre-clinical mRNA-delivered immune activator with strong IP with in-vivo and human epi survival data in both pediatric ($100M PRV) and $2B adult markets.
Company Website: http://www.merlinbiotech.com

Company HQ City

Doylestown

Company HQ State

PA

Company HQ Country

United States

CEO/Top Company Official

Randall N. Hyer
Speakers
Randall Hyer, MD
CEO
Merlin Biotech, Inc.
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS